Notice: UNCW Pauses COVID-19 Vaccination Clinic Based on State and Federal Guidance

Tuesday, April 13, 2021

UNCW has paused its COVID-19 vaccination clinic, which has been administering the Johnson & Johnson vaccine, immediately and until further notice, based on guidance from state and federal health authorities. 

Earlier this morning, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued a statement recommending a pause on the use of the J&J COVID-19 vaccine. Out of more than 6.8 million doses of the vaccine administered in the U.S., six recipients reported rare blood clots and symptoms occurred six to 13 days after vaccination. A joint statement from the FDA and the CDC provides more information here. To date, UNCW has not received any reports of similar health concerns among recipients vaccinated at the campus clinic. 

The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, to further review the six reported cases of blood clots in individuals who received the J&J vaccine and assess their potential significance. The FDA will review that analysis as it also investigates these cases. Until that process is complete, the North Carolina Department of Health and Human Services (NCDHHS) is recommending a pause in the use of this vaccine out of an abundance of caution. UNCW will share updates about the university clinic’s operations and appointment rescheduling as information becomes available. 

According to the FDA and CDC statement, if you experience a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, please contact your health care provider. If, after reviewing the CDC statement, you have additional questions, please email